In non-small cell lung cancer, miR-106b-25 cluster targets b-TRCP2 and enhances cell migration and invasion [60], while in acute myeloid leukemia (AML), it targets CASP7, influencing cell proliferation, chemoresistance, and apoptosis [61]. The gene discussed is CASP7; the disease is acute myeloid leukemia.